Abstract:Background
Neuropsychological comparison of medulloblastoma (MB) and cerebellar low‐grade astrocytoma (LGA) survivors to controls can clarify treatment‐related neurocognitive late effects. While both brain tumor groups undergo surgery to the posterior fossa, children with MB additionally receive craniospinal irradiation with boost and chemotherapy. This study provides an updated comparison of neuropsychological functioning in these two groups and examines effects of demographic risk factors upon outcomes.
Proc… Show more
“…Our study, conducted on a fairly large sample of participants, confirms the results of other studies based on smaller samples showing that children who have survived cancer have cognitive and motor deficits [ 14 , 16 ]. Meanwhile, the large and varied clinical sample both in terms of the cancer survivor group and the control group could provide the solid rationale for improving and updating rehabilitation procedures aiming at restoring the neurocognitive and fine motor skills and potentially choosing the best pipeline for each individual patient, thus leading to potential improvements in cognitive outcomes and quality of life.…”
Section: Discussionsupporting
confidence: 89%
“…A lot of research has demonstrated negative outcomes for pediatric brain cancer survivors, among which a decrease in cognitive, visual-motor, and visuospatial functioning were the most common [ 14 ]. This might be related to several factors: location of tumor as well as tumor origin and progression, type of therapy (for instance resection of a part of the brain for the pediatric cancer of the central nervous system), chemotherapy and radiation therapy, the consequences of treatment and hospitalization, age and time of the diagnosis, duration of treatment, and many other factors [ 15 , 16 , 17 ]. A systematic review showed that tumor histopathology and subsequent adjuvant therapy as well as the age of diagnosis influenced later neuropsychological difficulties in CNS tumor survivors [ 18 ].…”
Background: The late treatment outcomes of pediatric brain tumors and of hematopoietic and lymphoid tissue tumors are an important focus of both rehabilitation and research. Neurocognitive and motor disorders induce further learning problems impeding social-emotional adaptation throughout a whole lifespan. Core deficits in short-term and working memory, visuospatial constructional ability, verbal fluency, and fine motor skills underlie distorted intellectual and academic achievement. This study aimed to assess the individual differences in cognitive ability and fine motor skills of pediatric tumor survivors and the age-matched healthy controls. Methods: A total of 504 tumor survivors after treatment and 646 age-matched healthy controls underwent neurocognitive and fine motor assessments. Findings: The group of tumor survivors scored significantly worse in both neurocognitive and fine motor skill in compared with the healthy control group. The pediatric brain tumor survivors (PBT group) performed worse in cognitive (p < 0.001 for verbal fluency and p < 0.001 for visuospatial constructional ability) and motor tests (p < 0.001) compared to the healthy controls. Hematopoietic and Lymphoid Tissues tumors survivors (THL group) performed worse in verbal fluency (p < 0.01) and visuospatial constructional test (p < 0.001) compared to the control group. Furthermore, the PBT group had worse results in visuospatial constructional ability (p < 0.05) and fine motor (p < 0.001) ability than the THL group. Significant differences between females and males were found in fine motor test performance in the PBT group (p < 0.05), as well as in verbal fluency (p < 0.01) and visuospatial constructional ability (p < 0.01) in the control group. Neurocognitive and fine motor skill characteristics in the THL group did not correlate with age.
“…Our study, conducted on a fairly large sample of participants, confirms the results of other studies based on smaller samples showing that children who have survived cancer have cognitive and motor deficits [ 14 , 16 ]. Meanwhile, the large and varied clinical sample both in terms of the cancer survivor group and the control group could provide the solid rationale for improving and updating rehabilitation procedures aiming at restoring the neurocognitive and fine motor skills and potentially choosing the best pipeline for each individual patient, thus leading to potential improvements in cognitive outcomes and quality of life.…”
Section: Discussionsupporting
confidence: 89%
“…A lot of research has demonstrated negative outcomes for pediatric brain cancer survivors, among which a decrease in cognitive, visual-motor, and visuospatial functioning were the most common [ 14 ]. This might be related to several factors: location of tumor as well as tumor origin and progression, type of therapy (for instance resection of a part of the brain for the pediatric cancer of the central nervous system), chemotherapy and radiation therapy, the consequences of treatment and hospitalization, age and time of the diagnosis, duration of treatment, and many other factors [ 15 , 16 , 17 ]. A systematic review showed that tumor histopathology and subsequent adjuvant therapy as well as the age of diagnosis influenced later neuropsychological difficulties in CNS tumor survivors [ 18 ].…”
Background: The late treatment outcomes of pediatric brain tumors and of hematopoietic and lymphoid tissue tumors are an important focus of both rehabilitation and research. Neurocognitive and motor disorders induce further learning problems impeding social-emotional adaptation throughout a whole lifespan. Core deficits in short-term and working memory, visuospatial constructional ability, verbal fluency, and fine motor skills underlie distorted intellectual and academic achievement. This study aimed to assess the individual differences in cognitive ability and fine motor skills of pediatric tumor survivors and the age-matched healthy controls. Methods: A total of 504 tumor survivors after treatment and 646 age-matched healthy controls underwent neurocognitive and fine motor assessments. Findings: The group of tumor survivors scored significantly worse in both neurocognitive and fine motor skill in compared with the healthy control group. The pediatric brain tumor survivors (PBT group) performed worse in cognitive (p < 0.001 for verbal fluency and p < 0.001 for visuospatial constructional ability) and motor tests (p < 0.001) compared to the healthy controls. Hematopoietic and Lymphoid Tissues tumors survivors (THL group) performed worse in verbal fluency (p < 0.01) and visuospatial constructional test (p < 0.001) compared to the control group. Furthermore, the PBT group had worse results in visuospatial constructional ability (p < 0.05) and fine motor (p < 0.001) ability than the THL group. Significant differences between females and males were found in fine motor test performance in the PBT group (p < 0.05), as well as in verbal fluency (p < 0.01) and visuospatial constructional ability (p < 0.01) in the control group. Neurocognitive and fine motor skill characteristics in the THL group did not correlate with age.
“…Conversely, studies of small samples of children and adolescents with craniopharyngioma have not demonstrated a relationship between excessive daytime sleepiness and cognitive outcomes such as attention and executive functions ( Jacola et al, 2016 ). A recent study identified a relationship between cognitive speed and fatigue among pediatric survivors of posterior fossa tumors ( Levitch et al, 2022 ), but this investigation did not isolate sleep disturbances as separate from fatigue. Sleep and fatigue are distinct concepts in pediatric oncology, with fatigue defined more as a lack of energy and feeling of exhaustion not necessarily associated with sleepiness ( Walter et al, 2015 ).…”
BackgroundPediatric brain tumor (PBT) survivors are at risk for developing sleep disturbances. While in other pediatric populations sleep disturbance has been associated with worse cognitive functioning, it is unclear to what extent this relationship generalizes to PBT survivors. The aim of the current study was to assess the relationship between sleep disturbance and aspects of cognition, including sluggish cognitive tempo (SCT) as well as attention and working memory.Materials and MethodsEighty-three PBT survivors 6–18 years of age who were at least 3 months post-treatment were included in the present cross-sectional study. Level of sleep disturbance was measured as a composite score reflecting various sleep problems as rated by caregivers. Cognitive measures included caregiver-ratings of sluggish cognitive tempo and attention problems, as well as performance-based cognitive measures assessing attention and executive functioning. Hierarchical regression analysis was used to assess associations between sleep and cognition.ResultsOf all caregivers, 32.5% reported one or more sleep disturbances as “very/often true” and over 68% of caregivers rated at least one sleep-related item as “somewhat true.” Of all cognitive variables, scores were most frequently impaired for SCT (30%). A higher level of sleep disturbance was associated with worse SCT and parent-rated attention problems. Associations between sleep and performance-based cognitive measures assessing attention and working memory were not statistically significant.ConclusionFindings of the current study highlight the importance of further investigation into the relationship between sleep and cognition in PBT survivors, which may assist efforts to maximize cognitive outcome and health-related quality of life in PBT survivors. The current study additionally suggests further investigation of SCT in this population is warranted, as it may be more sensitive to detecting possible associations with sleep disturbance relative to discrete measures that assess cognitive performance under ideal circumstances.
“…Moreover, pediatric brain tumor survivors (PBTS) typically also have neurocognitive and behavioral problems [4][5][6][7][8][9]. Given that cranial radiotherapy (RT) is associated with a high risk of neurotoxicity in PBTS, many survivorship studies have focused on the cognitive outcomes of PBTS [8][9][10][11][12][13][14], but very few studies have investigated the neurobehavioral outcomes.…”
Purpose: The neurocognitive outcomes of pediatric brain tumor survivors have been extensively studied but the risk and predictors for neurobehavioral impairment are less clearly defined. We systematically analyzed the rates of emotional, psychosocial, and attention problems in pediatric brain tumor survivors. Methods: PubMed, Web of Science, Embase, Scopus, and Cochrane were searched for articles published between January 2012 to April 2022. Eligible studies reported neurobehavioral outcomes for PBTS aged 2 to <23 years with a brain tumor diagnosis before 18 years of age. A random-effect meta-analysis was performed in R. Results: The search yielded 1187 unique publications, of which 50 were included in the quantitative analysis. The estimated risk of having emotional, psychosocial, and attention problems were 15% (95%CI 10–20%), 12% (95%CI 9–16%), and 12% (95%CI 9–16%), respectively. PBTS were more likely to have emotional difficulties (Hedge’s g = 0.43 [95%CI 0.34–0.52]), psychosocial problems (Hedge’s g = 0.46 [95%CI 0.33–0.58]), and attention problems (Hedge’s g = 0.48 [95%CI 0.34–0.63]) compared to normal/healthy control subjects. There was no significant difference in the rates of neurobehavioral impairment between children with and without history of cranial radiotherapy. Conclusions: PBTS are at elevated risk of neurobehavioral impairment. Neurobehavioral monitoring should be considered as the standard of care for PBTS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.